BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2020 11:49:18 AM | Browse: 1227 | Download: 2181
 |
Received |
|
2019-11-08 02:13 |
|
Peer-Review Started |
|
2019-11-08 02:15 |
|
First Decision by Editorial Office Director |
|
2019-12-23 17:57 |
|
Return for Revision |
|
2019-12-23 17:57 |
|
Revised |
|
2020-01-01 19:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-01-09 09:17 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-01-11 14:10 |
|
Articles in Press |
|
2020-01-11 14:10 |
|
Edit the Manuscript by Language Editor |
|
2020-02-03 05:47 |
|
Typeset the Manuscript |
|
2020-02-11 07:55 |
|
Publish the Manuscript Online |
|
2020-02-14 11:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun-Gang Luo, Li-Wei Duan, Xuan Ji, Wen-Yuan Jia, Yun Liu, Mao-Lei Sun and Guo-Min Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Min Liu, PhD, Director, Director, Jilin Provincial Medicine Anti-Tumor Engineering Center, The Second Hospital of Jilin University, No. 218, Ziqiang Street, Changchun 130041, Jilin Province, China. lgm@mail.jlu.edu.cn |
| Key Words |
miR-1304; Recurrence; Prognosis; Diagnosis; Bioinformatics analysis; The Cancer Genome Atlas |
| Core Tip |
In recent years, the morbidity and mortality of esophageal carcinoma have increased significantly. However, there are few clinical tumor markers related to esophageal carcinoma. miRNA is a hot research direction in recent years. This study analyzed the expression of miR-1304 in patients with esophageal carcinoma, and found that miR-1304 was highly expressed in them, and was an independent factor for recurrence and prognosis of esophageal carcinoma. miR-1304 was expected to become a potential index for predicting prognosis and recurrence of esophageal carcinoma. |
| Publish Date |
2020-02-14 11:49 |
| Citation |
Luo YG, Duan LW, Ji X, Jia WY, Liu Y, Sun ML, Liu GM. Expression of miR-1304 in patients with esophageal carcinoma and risk factors for recurrence. World J Gastroenterol 2020; 26(6): 670-685 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i6/670.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i6.670 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
